Koyama, T., Shimizu, T., Iwasa, S., Fujiwara, Y., Kondo, S., Kitano, S., . . . Yamamoto, N. (2020). First‐in‐human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumors. Cancer Sci.
Chicago-stil citatKoyama, Takafumi, et al. "First‐in‐human Phase I Study of E7090, a Novel Selective Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors." Cancer Sci 2020.
MLA-referensKoyama, Takafumi, et al. "First‐in‐human Phase I Study of E7090, a Novel Selective Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors." Cancer Sci 2020.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.